These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Progressive multifocal leukoencephalopathy occurring with the acquired immune deficiency syndrome. England JD; Hsu CY; Garen PD; Goust JM; Biggs PJ South Med J; 1984 Aug; 77(8):1041-3. PubMed ID: 6540476 [TBL] [Abstract][Full Text] [Related]
25. Papovavirus of JC type in progressive multifocal leukoencephalopathy. Rapid identification and subsequent isolation. Weiner LP; Narayan O; Penney JB; Herndon RM; Feringa ER; Tourtellotte WW; Johnson RT Arch Neurol; 1973 Jul; 29(1):1-3. PubMed ID: 4576212 [No Abstract] [Full Text] [Related]
26. [New papovaviruses in humans]. van Loghem JG; van der Noordaa J Ned Tijdschr Geneeskd; 1975 Jul; 119(27):1075-7. PubMed ID: 1094311 [No Abstract] [Full Text] [Related]
27. Etiology of progressive multifocal leukoencephalopathy. Identification of papovavirus. Narayan O; Penney JB; Johnson RT; Herndon RM; Weiner LP N Engl J Med; 1973 Dec; 289(24):1278-82. PubMed ID: 4356147 [No Abstract] [Full Text] [Related]
28. Identity of a newly isolated human polyomavirus from a patient with progressive multifocal leucoencephalopathy. Field AM; Gardner SD; Goodbody RA; Woodhouse MA J Clin Pathol; 1974 May; 27(5):341-7. PubMed ID: 4368786 [TBL] [Abstract][Full Text] [Related]
29. Distribution of papovavirus, myelin-associated glycoprotein, and myelin basic protein in progressive multifocal leukoencephalopathy lesions. Itoyama Y; Webster HD; Sternberger NH; Richardson EP; Walker DL; Quarles RH; Padgett BL Ann Neurol; 1982 Apr; 11(4):396-407. PubMed ID: 6179456 [TBL] [Abstract][Full Text] [Related]
30. Clinical and virological monitoring during treatment with intrathecal cytarabine in patients with AIDS-associated progressive multifocal leukoencephalopathy. De Luca A; Giancola ML; Cingolani A; Ammassari A; Gillini L; Murri R; Antinori A Clin Infect Dis; 1999 Mar; 28(3):624-8. PubMed ID: 10194089 [TBL] [Abstract][Full Text] [Related]
33. [Isolation and ultrastructural study of a Papova type virus not neutralized by the anti SV 40 reference serum during progressive multifocal leukoencephalopathy]. Cathala F; Hauw J; Escourolle R C R Acad Hebd Seances Acad Sci D; 1973 Feb; 276(6):1081-4. PubMed ID: 4350821 [No Abstract] [Full Text] [Related]
35. Serological and morphological studies on progressive multifocal leucoencephalopathy virus. Amako K; Mori R Jpn J Microbiol; 1972 Mar; 16(2):155-8. PubMed ID: 4538369 [No Abstract] [Full Text] [Related]
36. Prevalence of antibodies in human sera against JC virus, an isolate from a case of progressive multifocal leukoencephalopathy. Padgett BL; Walker DL J Infect Dis; 1973 Apr; 127(4):467-70. PubMed ID: 4571704 [No Abstract] [Full Text] [Related]
38. Isolation of virus related to SV40 from patients with progressive multifocal leukoencephalopathy. Weiner LP; Herndon RM; Narayan O; Johnson RT; Shah K; Rubinstein LJ; Preziosi TJ; Conley FK N Engl J Med; 1972 Feb; 286(8):385-90. PubMed ID: 4333082 [No Abstract] [Full Text] [Related]
39. Progressive multifocal leukoencephalopathy: a complication of immunosuppressive treatment. Sponzilli EE; Smith JK; Malamud N; McCulloch JR Neurology; 1975 Jul; 25(7):664-8. PubMed ID: 1171399 [TBL] [Abstract][Full Text] [Related]
40. Clustering of progressive multifocal cases of leukoencephalopathy. Brun A; Nordenfelt E; Palm L N Engl J Med; 1976 Dec; 295(27):1537. PubMed ID: 995165 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]